schneider said that he is "not aware of any relevant risk of the drug" and that his team has "not observed side effects in thousands of treated animals.".
.
cambridge's bluebird bio licenses delivery tech to novartis, gsk.
the situation has become so bad that a cross-party committee of politicians called it a.